-
Vertex Pharmaceuticals (NASDAQ:VRTX) Receives "Overweight" Rating from Cantor Fitzgerald
Source: Buzz FX / 25 Jan 2025 10:05:18 America/Chicago
Vertex Pharmaceuticals (NASDAQ:VRTX) Receives "Overweight" Rating from Cantor Fitzgerald Written by MarketBeat January 25, 2025 Share Link copied to clipboard. Vertex Pharmaceuticals ( NASDAQ:VRTX - Get Free Report ) 's stock had its "overw
Read more...